Log In
Print
BCIQ
Print
Print this Print this
 

Human anti-M2e antibody (TCN-032)

Also known as: influenza mAb

  Manage Alerts
Collapse Summary General Information
Company Theraclone Sciences Inc.
DescriptionRecombinant human mAb that specifically binds to a conserved epitope of the amino-terminal extracellular domain (M2e) of M2
Molecular Target Influenza A virus matrix protein M2 (M2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat influenza A infection; Treat influenza virus infection
Regulatory Designation

Partner

Zenyaku Kogyo Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today